Literature DB >> 7534927

Enrichment of fetal cells from maternal blood by high gradient magnetic cell sorting (double MACS) for PCR-based genetic analysis.

J Büsch1, P Huber, E Pflüger, S Miltenyi, J Holtz, A Radbruch.   

Abstract

For simple and effective isolation of fetal cells from peripheral maternal blood, we combined depletion of maternal cells and enrichment of fetal cells by high-gradient magnetic cell separation (MACS). First CD45+ and CD14+ cells were depleted from maternal peripheral blood mononuclear cells by MACS. From the depleted fraction, CD71+ erythroid cells were enriched up to 80 per cent by MACS. This double-MACS' procedure yielded an average depletion rate of 780-fold and an average enrichment rate of 500-fold, with approximate recovery rates of 40-55 per cent. For paternity testing, cells from unseparated blood and the various fractions were analysed for polymorphism of the HLA-DQ-A1 locus and D1S80 locus by the polymerase chain reaction (PCR). In CD45-/CD71+ sorted cells from maternal blood, but not in unfractionated cells from maternal blood or CD45-/CD14- cells, paternal alleles could be detected. In the CD45-/CD71+ fraction, the relative frequency of paternal alleles compared with maternal alleles ranged from 1 in 20 to 1 in 200 (determined by titration and depending on the quality of separation and biological variation). In 7 out of 11 cases, between weeks 12 and 25 of gestation, we could identify paternal alleles by PCR, either HLA-DQ-A1 or D1S80. This double-MACS procedure is simple, fast, efficient, and reliable for non-invasive prenatal diagnosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7534927     DOI: 10.1002/pd.1970141206

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  7 in total

1.  Development of the "Three-step MACS": a novel strategy for isolating rare cell populations in the absence of known cell surface markers from complex animal tissue.

Authors:  Mathia Y Lee; Thomas Lufkin
Journal:  J Biomol Tech       Date:  2012-07

2.  Maternal origin of nucleated erythrocytes in peripheral venous blood of pregnant women.

Authors:  A Slunga-Tallberg; W el-Rifai; M Keinänen; K Ylinen; T Kurki; K Klinger; O Ylikorkala; S Knuutila
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132

3.  A microfluidics approach for the isolation of nucleated red blood cells (NRBCs) from the peripheral blood of pregnant women.

Authors:  R Huang; T A Barber; M A Schmidt; R G Tompkins; M Toner; D W Bianchi; R Kapur; W L Flejter
Journal:  Prenat Diagn       Date:  2008-10       Impact factor: 3.050

4.  Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications.

Authors:  Elisavet A Papageorgiou; Philippos C Patsalis
Journal:  Genome Med       Date:  2012-05-28       Impact factor: 11.117

5.  Non-invasive Prenatal Diagnosis of Chromosomal Aneuploidies and Microdeletion Syndrome Using Fetal Nucleated Red Blood Cells Isolated by Nanostructure Microchips.

Authors:  Chun Feng; Zhaobo He; Bo Cai; Jianhong Peng; Jieping Song; Xuechen Yu; Yue Sun; Jing Yuan; Xingzhong Zhao; Yuanzhen Zhang
Journal:  Theranostics       Date:  2018-02-02       Impact factor: 11.556

6.  Isolation of HLA-G+ cells using MEM-G/9 antibody-conjugated magnetic nanoparticles for prenatal screening: a reliable, fast and efficient method.

Authors:  Elaheh Emadi; Abdol-Khalegh Bordbar; Hamid Nadri; Ali Shams; Asghar Taheri-Kafrani; Seyed Mehdi Kalantar
Journal:  RSC Adv       Date:  2021-09-20       Impact factor: 4.036

7.  A photoelectrochemical platform for the capture and release of rare single cells.

Authors:  Stephen G Parker; Ying Yang; Simone Ciampi; Bakul Gupta; Kathleen Kimpton; Friederike M Mansfeld; Maria Kavallaris; Katharina Gaus; J Justin Gooding
Journal:  Nat Commun       Date:  2018-06-12       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.